个体参与者数据荟萃分析中治疗效应与协变量交互作用的统计学推荐
本文为开展和规划个体参与者数据(IPD)荟萃分析以检验治疗-协变量交互作用提供统计学推荐。实施方面推荐直接估计交互作用、仅基于研究内信息、连续变量按连续尺度分析、用多元荟萃分析检查非线性关系,并将交互作用转化为个体化治疗效应预测。规划方面建议不应基于总体治疗效应的研究间异质性决定是否启动IPD项目,并描述了在收集IPD前计算把握度的方法。
要点
- 交互作用应直接估计,而非通过比较亚组荟萃分析结果的差异。
- 交互作用估计应仅基于研究内信息,连续协变量和结局按连续尺度分析。
- 启动IPD荟萃分析项目不应基于总体治疗效应的研究间异质性。
核心结论
- IPD荟萃分析检验治疗-协变量交互作用时,应直接估计交互作用并仅基于研究内信息。
- 连续协变量和结局应按连续尺度分析,并用多元荟萃分析检查非线性关系。
- 交互作用转化为临床实践需进行个体化治疗效应预测。
- 是否启动IPD荟萃分析项目不应基于总体治疗效应的研究间异质性。
- 可在收集IPD前基于试验特征计算潜在IPD荟萃分析项目的把握度。
研究设计与样本
- 本文为统计学推荐,针对随机试验的IPD荟萃分析,描述了两阶段和一阶段统计模型,并用真实IPD荟萃分析项目示例说明。
关键数值与推荐
- 推荐直接估计交互作用,而非计算亚组荟萃分析结果的差异。
- 推荐交互作用估计仅基于研究内信息。
- 推荐连续协变量和结局按连续尺度分析。
- 推荐用多元荟萃分析(如限制性立方样条函数)检查连续协变量的非线性关系。
- 推荐将交互作用转化为临床实践时进行个体化治疗效应预测。
临床怎么用
- 开展IPD荟萃分析检验治疗-协变量交互作用时,直接估计交互作用并仅使用研究内信息。
- 分析连续协变量时按连续尺度处理,并用多元荟萃分析检查非线性关系。
- 将交互作用转化为临床实践需进行个体化治疗效应预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Precision medicine research often searches for treatment-covariate interactions, which refers to when a treatment effect (eg, measured as a mean difference, odds ratio, hazard ratio) changes across values of a participant-level covariate (eg, age, gender, biomarker). Single trials do not usually have sufficient power to detect genuine treatment-covariate interactions, which motivate the sharing of individual participant data (IPD) from multiple trials for meta-analysis. Here, we provide statistical recommendations for conducting and planning an IPD meta-analysis of randomized trials to examine treatment-covariate interactions. For conduct, two-stage and one-stage statistical models are described, and we recommend: (i) interactions should be estimated directly, and not by calculating differences in meta-analysis results for subgroups; (ii) interaction estimates should be based solely on within-study information; (iii) continuous covariates and outcomes should be analyzed on their continuous scale; (iv) nonlinear relationships should be examined for continuous covariates, using a multivariate meta-analysis of the trend (eg, using restricted cubic spline functions); and (v) translation of interactions into clinical practice is nontrivial, requiring individualized treatment effect prediction. For planning, we describe first why the decision to initiate an IPD meta-analysis project should not be based on between-study heterogeneity in the overall treatment effect; and second, how to calculate the power of a potential IPD meta-analysis project in advance of IPD collection, conditional on characteristics (eg, number of participants, standard deviation of covariates) of the trials (potentially) promising their IPD. Real IPD meta-analysis projects are used for illustration throughout.
引用
- Riley RD, Debray TPA, Fisher D, et al. Individual participant data meta-analysis to examine interactions between treatment effect and participant-level covariates: Statistical recommendations for conduct and planning. Stat Med. 2020. PMID: 32350891. doi:10.1002/sim.8516
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。